150 results
8-K
MNKTQ
Mallinckrodt plc
11 Mar 22
Entry into a Material Definitive Agreement
5:11pm
, the “Mallinckrodt Parties”) had agreed to a settlement in principle with the United States of America, acting through the United States Department of Justice … and on behalf of the Office of Inspector General of the Department of Health and Human Services (collectively, the “United States”), certain other
8-K
EX-14.2
MNKTQ
Mallinckrodt plc
1 Jul 13
Mallinckrodt plc Begins Trading on New York Stock Exchange
12:00am
Department representative;
Mallinckrodt Pharmaceuticals’ toll-free Integrity Hotline at (888) 696-9864(US and Canada). Directions for dialing the Integrity … , Mallinckrodt Pharmaceuticals’ Privacy and Data Security Officer, a Human Resources representative, a Legal Department representative, Mallinckrodt
8-K
EX-10.2
MNKTQ
Mallinckrodt plc
11 Mar 22
Entry into a Material Definitive Agreement
5:11pm
the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS … Division of the Department of Justice has actual and present authority to assert and compromise pursuant to 28 CFR Part 0; Subpart I, 0.45(d
8-K
MNKTQ
Mallinckrodt plc
13 Oct 20
Mallinckrodt Secures Broad Consensus with Key Stakeholders on Comprehensive Chapter 11 Restructuring
6:45am
with respect to the operation of its opioid business.
A proposed resolution with the U.S. Department of Justice and other governmental parties to settle … Events.
The Company has reached an agreement in principle with the U.S. Department of Justice and other governmental parties to settle a range
425
MNKTQ
Mallinckrodt plc
11 Aug 14
Business combination disclosure
12:00am
or by contacting Mallinckrodt’s Investor Relations Department at (314) 654-6650. Copies of documents filed with the SEC by Questcor will be available free … of charge on Questcor’s internet website atwww.questcor.com or by contacting Questcor’s Investor Relations Department at (714) 497-4899.
8-K
eqdmys7
3 May 22
Bankruptcy or Receivership
4:37pm
8-K/A
nam67cy3 jlo
1 Jul 22
Bankruptcy or Receivership
5:10pm
8-K
EX-10.1
dfi3r2o5przmi v2
11 Mar 22
Entry into a Material Definitive Agreement
5:11pm
425
9hqhjr b2kk
24 Apr 14
Business combination disclosure
12:00am
425
bgiw0srnvsdkdep94
12 May 14
Business combination disclosure
12:00am
425
v1mbz44
7 Apr 14
Business combination disclosure
12:00am
425
f6cw84gawe760b74
11 Aug 14
Business combination disclosure
12:00am
425
op5etceu1gw4jts9kuw
7 Apr 14
Business combination disclosure
12:00am
425
sj2ik299i
11 Aug 14
Business combination disclosure
12:00am
425
jhz02nl iicmk
7 Apr 14
Business combination disclosure
12:00am
425
kfief9zqjg66cj5
7 Apr 14
Business combination disclosure
12:00am
425
fyyv0jauxo 6aa15m
11 Aug 14
Business combination disclosure
12:00am
425
8n7e64
7 Apr 14
Business combination disclosure
12:00am
8-K
x2h thbvf
7 Apr 14
Pharmaceuticals Enter into Definitive Merger Agreement
12:00am
8-K
y22bv0
21 May 19
Other Events
10:23am